11 March 2002
Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients.
Andrew M Thornett, Laurence M Mynors-WallisMed Sci Monit 2002; 8(3): CR193-196 :: ID: 420903
Abstract
BACKGROUND: Patient beliefs in the effectiveness of treatment may havean important influence on treatment outcome. MATERIAL/METHODS: Associations between patient beliefs inthe credibility of treatment and outcome were explored in a randomised controlled trial of major depressionin primary care (n=155). The four treatments were antidepressant medication given by research generalpractitioner, problem solving treatment given by research general practitioner or research practice nurseover 12 weeks or a combination of problem solving treatment and antidepressant medication. Patients'belief in the credibility of treatment was assessed using a brief Credibility Scale, that was completedfollowing randomisation and after treatment. Depression outcome was measured at 6, 12 and 52 weeks usingthe Hamilton Rating Scale for depression, and the Beck depression inventory. RESULTS: Pre-treatment,medication treatment was associated with a higher certainty of recovery than was problem-solving treatmentfrom the nurse (p=0.018). Post-treatment, medication and combination treatment were seen as more logicalthan problem-solving treatment from the nurse (p<0.03). Post-treatment medication had higher certainty of recovery and was more highly recommended to a friend. Linear regression demonstrated that the depression outcome measures were not associated with either pre- or post-treatment credibility.
Conclusions: Patients found all four treatments highly credible following their initial explanation. There was a significant difference both pre- and post-treatment in favour of patients finding treatment involving medication more credible than problem-solving from a nurse. Pre- and post-treatment scores of credibility were not associated with outcome
Keywords: Adolescent, Antidepressive Agents, Second-Generation, Depression, fluvoxamine, paroxetine, Psychotherapeutic Processes, Time Factors
Editorial
01 February 2025 : Editorial
Editorial: Current Approaches to Screening for Lung Cancer in Smokers and Non-SmokersDOI: 10.12659/MSM.948255
Med Sci Monit 2025; 31:e948255
In Press
Review article
Hydrogels in Oral Disease Management: A Review of Innovations in Drug Delivery and Tissue RegenerationMed Sci Monit In Press; DOI: 10.12659/MSM.946122
Clinical Research
Procedure Dynamics in Transfemoral vs Transradial Cerebral Angiography: A Retrospective StudyMed Sci Monit In Press; DOI: 10.12659/MSM.947603
Clinical Research
Predicting Cerebral Small Vessel Disease Burden Based on Thromboelastography in Patients with Acute Ischemi...Med Sci Monit In Press; DOI: 10.12659/MSM.946303
Clinical Research
Long-Term Outcomes of Implanon in Managing Adenomyosis: A 3-Year Prospective StudyMed Sci Monit In Press; DOI: 10.12659/MSM.945972
Most Viewed Current Articles
17 Jan 2024 : Review article 6,969,459
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 701,879
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 25,628
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 20,173
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912